期刊文献+

乳腺癌免疫活性细胞反应的意义及淋巴结转移的危险因素分析 被引量:1

下载PDF
导出
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2008年第2期239-241,共3页 Chinese Journal of Clinical and Experimental Pathology
基金 南通市社会发展计划项目(2006-S6848)
  • 相关文献

参考文献4

二级参考文献30

  • 1[1]Meazza R,Gaggero A,Neglia F,et al.Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion: role of different signal peptides [J].Eur J Immunol,1997:27(5):1049
  • 2[2]Carosella ED,Rouas-Freiss N,Paul P,et al.HLA-G: a tolerance molecule from the major histocompatibility complex [J].Immunol Today,1999:20(2):60
  • 3[3]D'Orazio TJ,Niederkorn JY.A novel role for TGF-beta and IL-10 in the induction of immune privilege [J].J Immunol,1998:160(5):2089
  • 4[4]Salazar-Onfray F.Interleukin-10: a cytokine used by tumors to escape immunosurveillance [J].Med Oncol,1999:16(2):86
  • 5[5]Chouaib S,Asselin-Paturel C,Mami-Chouaib F,et al.The host-tumor immune conflict: from immunosuppression to resistance and destruction [J].Immunol Today,1997:18(10):493
  • 6[6]Matsni S,Ahlers JD,Vortmeyer AO,et al.A model for CD8+ CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL [J].J Immunol,1999:163(1):184
  • 7[7]Adler AJ,Marsh DW,Yochum GS,et al.CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells [J].J Exp Med,1998:187(10):1555
  • 8[8]O'Connell J,Bennett MW,O'Sullivan GC,et al.The Fas counterattack: cancer as a site of immune privilege [J].Immunol Today,1999:20(1):46
  • 9[9]Zia A,Schildberg FM,Funke I.MHC class Ⅰ negative phenotype of disseminated tumor cells in bone marrow is associated with poor survival in ROMO breast cancer patients [J].Int J Cancer,2001:93(4):566
  • 10[10]Feinmesser M,Sulkes A,Morgenstern S,et al.HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities [J].J Clin Pathol,2000:53(4):286

共引文献4

同被引文献13

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2张丰,李楠.p27的功能调控及其在乳腺肿瘤治疗中的应用[J].中国肿瘤生物治疗杂志,2006,13(5):397-399. 被引量:4
  • 3赵勇,高建飞,饶智国,欧武陵,朱宇泽,杜光祖.胃癌中Cks1、p27^(Kip1)和Skp2蛋白的表达[J].肿瘤防治研究,2007,34(2):118-120. 被引量:7
  • 4张宏艳,刘端祺,范萍,黄其敏,侯新燕,彭雁,矫健,吕楠.乳腺癌普查初步报道及资料分析[J].解放军医学杂志,2007,32(6):654-654. 被引量:49
  • 5Sitry D,Seeliger MA,Ko TK,et al.Three different binding sites of Cksl are required for p27-ubiquitin ligation[].Journal of Biological Chemistry.2002
  • 6Shapira M,Ben-Izhak O,Linn S,et al.The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma[].Cancer.2005
  • 7Arber N,Doki Y,Han E K,et al.Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells[].Cancer Research.1997
  • 8Merav Slotky,Maanit Shapira,Ofer Ben-Izhak,et al.The expressionof the ubiquitin ligase subunit Cks1 in human breast cancer[].BreastCancer Research.2005
  • 9Bilalovic N,Vranic S,Basic H, et al.Immunohistochemical evaluation of cyclinD1 in breast cancer[].Croatian Medical Journal.2005
  • 10M Fu,C Wang,Z Li.Minireview: cyclin D1: normal and abnormal functions[].The Journal of Endocrinology.2004

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部